Skip to content
PubMed This is a summary of 55 peer-reviewed journal articles Updated
Neurology

Periventricular Nodular Heterotopia (PVNH): A Patient Guide

At a Glance

Periventricular nodular heterotopia (PVNH) is a brain-development difference that may cause no symptoms or may be linked with seizures, learning differences, or developmental delays. MRI findings and genetic testing help determine whether neurologic or heart and lung monitoring is needed.

Periventricular Nodular Heterotopia (PVNH) is a structural difference in the brain that occurs during fetal development. In a typically developing brain, neurons (nerve cells) are born near the center of the brain and travel outward to form the cerebral cortex, the area responsible for thinking and movement. In PVNH, some of these neurons do not complete their journey and instead form small, ectopic gray-matter clumps or “nodules” along the walls of the brain’s fluid-filled spaces, called ventricles [1][2].

While the discovery of these nodules on an MRI can be startling, it is not a direct predictor of a person’s future health or abilities. The clinical experience of PVNH varies significantly from one person to another. Many individuals lead typical lives with no medical symptoms and may only be diagnosed after a scan is performed for an unrelated reason. For others, PVNH can be associated with epilepsy, learning differences, or developmental delays [3][4]. Importantly, the number or size of the nodules seen on a scan does not always correlate with the severity of a person’s symptoms [1].

The underlying cause of PVNH is often genetic, with the FLNA gene being the most common known cause in particular familial or bilateral patterns. Because this gene helps build structural scaffolding for cells throughout the body, certain types of PVNH—particularly those related to FLNA—are considered multisystem conditions. This means that in addition to neurological care, these patients require monitoring of their heart, blood vessels, and lungs to manage risks such as aortic dilation or pulmonary hypertension [5][6]. However, systemic surveillance is not automatically indicated for isolated PVNH without a relevant genetic or syndromic suspicion.

What Happens Next?

If you have just received this diagnosis, consider these next steps:

  1. Confirm the MRI interpretation with a neurologist, specifically asking if it is isolated or involves other brain areas.
  2. Review symptoms and development to decide whether an EEG is indicated.
  3. Refer for genetic counseling and targeted testing when the pattern or family history warrants it.
  4. Reserve cardiopulmonary screening for when genetic results or clinical context indicates it.

Living with PVNH is a highly individualized journey that benefits from a proactive, multidisciplinary care team. By combining the expertise of neurologists, geneticists, and cardiologists, patients and families can create a comprehensive plan for long-term monitoring. While the diagnosis represents a permanent change in brain structure, it is a condition that can be managed with the right support, allowing many individuals to navigate their daily lives while ensuring those who need long-term educational, developmental, or seizure support receive it [4][7].

Common questions in this guide

What is periventricular nodular heterotopia (PVNH)?
PVNH is a difference in brain development where some nerve cells remain in small clusters along the walls of the brain’s fluid-filled spaces instead of moving to the outer brain layer. It may cause no symptoms, or it may be associated with seizures, learning differences, or developmental delays.
Does the number of PVNH nodules predict how severe symptoms will be?
No. The number or size of nodules seen on MRI does not reliably predict whether someone will have symptoms or how significant they will be. People with similar scans can have very different experiences.
What evaluations are usually considered after PVNH is found on an MRI?
A neurologist can review the MRI to determine whether PVNH is isolated or accompanied by other brain changes. The care team may review seizures and development, consider an EEG when indicated, and recommend genetic counseling or targeted testing when the pattern or family history suggests it.
When is genetic testing useful for someone with PVNH?
Genetic counseling and targeted testing may be useful when PVNH has a familial or bilateral pattern, when there is a relevant family history, or when other clinical findings suggest a genetic syndrome. FLNA is the most common known gene associated with certain familial or bilateral PVNH patterns.
Does everyone with PVNH need heart and lung screening?
No. Heart and lung monitoring is generally considered when FLNA-related or syndromic PVNH is suspected based on genetic results or clinical context. It is not automatically needed for isolated PVNH without that concern.
How is PVNH managed over time?
Management is individualized and may involve neurology, genetics, and cardiology, with additional specialists when needed. Care can include seizure management, developmental and educational support, and cardiopulmonary follow-up when genetic or clinical findings warrant it.
Should family members be tested if someone has PVNH?
Family testing is not automatically needed for every person with PVNH. If the MRI pattern, genetic result, or family history suggests an inherited form, a genetic counselor can advise whether targeted testing is appropriate for relatives.

Get notified when new evidence is published on Periventricular nodular heterotopia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    Phenotypic and imaging features of FLNA-negative patients with bilateral periventricular nodular heterotopia and epilepsy.

    Fallil Z, Pardoe H, Bachman R, et al.

    Epilepsy & behavior : E&B 2015; (51()):321-7.

    PMID: 26340046
  2. 2

    Malformations of Cortical Development: From Postnatal to Fetal Imaging.

    Lerman-Sagie T, Leibovitz Z

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2016; (43(5)):611-8 doi:10.1017/cjn.2016.271.

    PMID: 27670206
  3. 3

    Magnetic resonance imaging features of isolated periventricular heterotopia in pediatric epilepsy: a comparative study

    Tittle BJ, Maheshwari M, Marashly A

    Epileptic disorders : international epilepsy journal with videotape 2022; (24(5)):795-802 doi:10.1684/epd.2022.1450.

    PMID: 35792848
  4. 4

    47 patients with FLNA associated periventricular nodular heterotopia.

    Lange M, Kasper B, Bohring A, et al.

    Orphanet journal of rare diseases 2015; (10()):134 doi:10.1186/s13023-015-0331-9.

    PMID: 26471271
  5. 5

    Thoracic aortic aneurysm in patients with loss of function Filamin A mutations: Clinical characterization, genetics, and recommendations.

    Chen MH, Choudhury S, Hirata M, et al.

    American journal of medical genetics. Part A 2018; (176(2)):337-350 doi:10.1002/ajmg.a.38580.

    PMID: 29334594
  6. 6

    "Phenotypic and genotypic insights, counseling strategies, and follow-up in 24 individuals with filamin a deficiency: findings from a retrospective cohort study".

    Rijckmans E, De Strooper L, Keymolen K, et al.

    Acta neurologica Belgica 2025; (125(5)):1347-1356 doi:10.1007/s13760-025-02858-0.

    PMID: 40758172
  7. 7

    [Periventricular nodular heterotopia : a pediatric case].

    Ebetiuc I, Bulk S, Leroy P

    Revue medicale de Liege 2019; (74(7-8)):388-390.

    PMID: 31373451

This page explains PVNH, MRI findings, genetic evaluation, and possible multisystem monitoring for informational purposes only; it does not constitute medical advice. Your neurologist, genetic counselor, and other clinicians should interpret your results and recommend care for your situation.